Starsis en es it fr

Starsis Brand names, Starsis Analogs

Starsis Brand Names Mixture

  • No information avaliable

Starsis Chemical_Formula


Starsis RX_link

Starsis fda sheet

Starsis FDA

Starsis msds (material safety sheet)

Starsis Synthesis Reference

No information avaliable

Starsis Molecular Weight

317.423 g/mol

Starsis Melting Point

No information avaliable

Starsis H2O Solubility

Practically insoluble

Starsis State


Starsis LogP


Starsis Dosage Forms

Tablets (60, 120 mg)

Starsis Indication

For use as monotherapy to lower blood glucose in patients with Type 2 diabetes (non-insulin dependent diabetes mellitus, NIDDM) whose hyperglycemia cannot be adequately controlled by diet and physical exercise and who have not been chronically treated with other anti-diabetic agents. Also indicated for use in combination with metformin.

Starsis Pharmacology

Nateglinide is an amino-acid derivative that lowers blood glucose levels by stimulating insulin secretion from the pancreas. This action is dependent upon functioning beta-cells in the pancreatic islets.

Starsis Absorption

Rapidly absorbed following oral administration prior to a meal, absolute bioavailability is estimated to be approximately 73%.

Starsis side effects and Toxicity

An overdose may result in an exaggerated glucose-lowering effect with the development of hypoglycemic symptoms.

Starsis Patient Information

Starsis Organisms Affected

Humans and other mammals